✦ LIBER ✦

Pharmacokinetics and clinical effects of cefuroxime in patients with severe renal insufficiency

✍ Scribed by R. A. Walstad; O. G. Nilsen; K. J. Berg

Publisher: Springer
Year: 1983
Tongue: English
Weight: 722 KB
Volume: 24
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf00610061

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of ramipril in hyperten

Pharmacokinetics of ramipril in hypertensive patients with renal insufficiency

✍ H. Schunkert; J. Kindler; M. Gassmann; W. Lahn; R. Irmisch; E. Ritz; E. R. Debus 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 958 KB

Cyclophosphamide pharmacokinetics and do

Cyclophosphamide pharmacokinetics and dose requirements in patients with renal insufficiency

✍ Haubitz, Marion; Bohnenstengel, Frank; Brunkhorst, Reinhard; Schwab, Matthias; H 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 219 KB

## Background: Intravenous pulse administration of cyclophosphamide (cyc) has been successfully used for the treatment of various autoimmune diseases. these patients often present with impaired renal function or even end-stage renal failure. nevertheless, data concerning pharmacokinetics of cyc in

Pharmacokinetics of cefadroxil in normal

Pharmacokinetics of cefadroxil in normal subjects and in patients with renal insufficiency

✍ G. Humbert; A. Leroy; J. P. Fillastre; M. Godin 📂 Article 📅 1980 🏛 Springer-Verlag 🌐 English ⚖ 890 KB

Pharmacokinetics of tocainide in patient

Pharmacokinetics of tocainide in patients with severe renal failure

✍ J. Braun; F. Sörgel; F. Engelmaier; W. P. Gluth; U. Geßler 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 740 KB

Pharmacokinetics of bendazac-lysine and

Pharmacokinetics of bendazac-lysine and 5-hydroxybendazac in patients with renal insufficiency

✍ V. Rovei; G. Campistron; J. -M. Dueymes; D. Ego; J. J. Conte; G. Houin 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 702 KB

Pharmacokinetic profile and tolerability

Pharmacokinetic profile and tolerability of pimobendan in patients with terminal renal insufficiency

✍ M. Przechera; W. Roth; V. Kühlkamp; T. Risler; M. Haehl 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 450 KB

The pharmacokinetics of an i.v. bolus of pimobendan (P) 2.5 mg and 5.0 mg, its tolerability and the effect on heart rate and blood pressure have been studied in 12 subjects (42-70 y) suffering from severe terminal renal impairment. Plasma level data were compared with those obtained in a previous in